Advocates for eye and vision research attending the Association for Research in Vision and Ophthalmology (ARVO) 2025 annual meeting were told they must unite now to thwart attempts by President Donald
Researchers in Australia found eyecare professionals grading retinal photographs with a structured visual search strategy diagnosed diabetic retinopathy (DR) with higher accuracy than those scanning f
This year’s edition of Myopia Awareness Week homes in on the need for outdoor time and balanced near-work, calling for considered lifestyle changes to protect vision. With myopia rates rising a
A team of international researchers found evidence that the herpes zoster (HZ) vaccination prevents or delays dementia. Led by Stanford University’s Dr Michael Pomirchy, a social scientist, the t
UK prime minister Sir Keir Starmer has announced substantial NHS reforms designed to reduce bureaucracy, make savings and empower NHS staff.
Under new Australian Health Practitioner Regulation Agency (Ahpra) and the National Boards measures, patients will be able to access the disciplinary record of practitioners proven to have committed sexual misconduct.
US researchers have shown drops derived from pigment epithelium-derived factor (PEDF) slowed progression in mouse models of retinitis pigmentosa (RP) and dry age-related macular degeneration.
Researchers from The Alfred hospital in Melbourne and the Auckland Bioengineering Institute (ABI) explored how human digital twins – computerised models of individual patients – can predict responses to surgery or medication.
Newly added to Goodlite’s range at Medix 21 is the Karickhoff macular acuity test (K-MAT), a quick and easy test for patients whose cataracts, corneal scars or vitreous haze prevent eyecare professionals (ECPs) from seeing their maculas at the slit lamp.
Researchers in Hong Kong found new evidence associating myopia with variants of a single gene and suggested age-related macular degeneration (AMD) and myopia may have shared genetic components.
Cocoa extract is showing promise in decreasing acute macular degeneration (AMD) risk, according to a US study published in JAMA Ophthalmology.
Adding real-world data and insights to years of positive clinical trial results, UK consultant ophthalmologist and medical retina specialist Dr Christiana Dinah was the keynote speaker at a recent closed-door event for Vabysmo (faricimab, Roche).